SOMERSET, N.J., April 02, 2018 -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based EHR and practice management solutions, today announced that Ryan Howard, founder and former CEO of Practice Fusion, has joined MTBC as Special Advisor to the CEO. In this role, he will be providing strategic guidance to support the growth of MTBC’s next generation EHR, talkEHR.
“Ryan is an accomplished strategist and thought leader who built the largest cloud-based physician-patient platform in the United States by offering a free EHR,” said Stephen Snyder, MTBC CEO. “We share Ryan’s disruptive vision of empowering healthcare providers with a top-tier, free EHR and are thrilled that he will be helping support our continued growth.”
“I’m very pleased to join MTBC as Special Advisor to the CEO” said Howard. “Having spent much of the last decade building the largest physician-patient platform in the United States, I look forward to supporting MTBC’s full launch and growth of talkEHR.”
talkEHR is designed to utilize natural language processing and artificial intelligence to automate key components of patient charting and reduce manual tasks and errors. It is offered completely free of cost to healthcare providers. talkEHR users are also eligible to upgrade to MTBC's premium, end-to-end medical billing solution, which is offered at one of the lowest price points in the industry.
Howard, a serial entrepreneur and industry veteran, founded Practice Fusion in 2005. Under his leadership, Howard grew Practice Fusion into one of the largest physician-patient platforms in the United States. In 2016, Howard founded iBeat, a wearable technology company, which he continues to lead as CEO.
About MTBC
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on Twitter, LinkedIn and Facebook.
SOURCE MTBC
Disclaimer:
This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Disclaimer
Practice Fusion® is a registered trademark of Practice Fusion and its use does not imply an endorsement or approval of MTBC, its products or this press release.
Company Contact: Rachel Grossinger Marketing Manager Medical Transcription Billing, Corp. [email protected] 732-873-5133 Investor Contact: Bill Korn Chief Financial Officer Medical Transcription Billing, Corp. [email protected] 732-873-5133


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Anta Sports Expands Global Footprint With Strategic Puma Stake
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



